| Information about this clinic: | |
At Clinilabs, a state-of-the-art research facility in midtown Manhattan and Eatontown, NJ, our goal is to facilitate efficient, expedited drug development that ultimately may provide those in need with new and effective therapies. Performing clinical research studies is imperative to this mission.
All research activities at Clinilabs are performed strictly under federal regulations and with respect to the Good Clinical Practices guidelines. Our research staff empowers study participants by educating them about clinical research and subsequently enabling them to make informed decisions regarding their study participation.
| | | |
| Not Provided. | | | |
| Not Provided. | | | |
Contact Us Today.
423 West 55th Steet, 4th Floor
New York, NY 10019
4 Industrial Way West
Eatontown, NJ 07724
212.994.4567
participate@clinilabs.com
www.clinilabs.com/volunteers
| | | |
| Clinilabs is a contract research organization (CRO) that provides clinical drug development services to industry. We manage studies at investigator sites Worldwide, and we operate our own clinical research units (CRUs) in midtown Manhattan and Eatontown, NJ. The goal of the CRUs is to conduct studies that help pharmaceutical companies develop new treatments for medical disorders – treatments that represent new and effective therapies that help those in need. Clinilabs’ dedicated, friendly research staff includes doctors, nurses, clinical research coordinators, pharmacists, laboratory personnel, and subject recruiters who have extensive experience in conducting clinical studies. Our clinicians are affiliated with prestigious institutions such as Columbia University of New York and Thomas Jefferson University and Hospital of Philadelphia; and our organization is affiliated with the New York Medical College and its associate hospitals. | | |
|
| Employees at this clinic: | | Gary Zammit | | President and CEO | | p. (646) 215.6400 | | e. info@clinilabs.com | Gary Zammit, Ph.D. is the President and CEO of Clinilabs, Inc., a specialty contract research organization he founded in 2001. Prior to assuming his current position, Dr. Zammit served as President of Pharmasys International, a clinical drug development consulting firm he founded in 1995.
Dr. Zammit currently is a Clinical Associate Professor of Psychology (in Psychiatry) at the Columbia University College of Physicians and Surgeons. He earned a PhD degree in clinical psychology from the University of Toledo (Toledo, Ohio), where he won the Turin Service Award and the Leckie Scholar Award. Dr. Zammit completed an internship and fellowship in the Department of Psychiatry at the New York Hospital - Cornell University Medical College, where he won the Alumni Award for Excellence. Dr. Zammit is widely known as a key opinion leader in the field of clinical drug development, has authored more than 80 original reports and two books, and currently serves as an advisor to several pharmaceutical companies and non-profit organizations.
| | |
| | | Magdy Shenouda | | Principle Investigator | | p. (646) 215.6400 | | e. info@clinilabs.com | | Dr. Magdy Shenouda is a physician who is board certified in internal medicine. He is a graduate, with honors, of the Ain-Shams Medical School, one of the most prestigious medical schools in Egypt. Magdy completed his residency at the Jersey Shore University Hospital in Neptune, NJ, after which he worked as an investigator and principal investigator at Phoenix International CRO, MDS Pharma, and Iberica. Magdy has over 17 years of clinical trial experience and has completed a variety of Phase I studies including: Intravenous studies, subcutaneous studies, cardiovascular studies, QTC studies, telemetry studies, nasogastric studies, patch studies, CNS studies, drug-drug interaction studies, bleeding studies, skin punch biopsy studies, intranasal studies, and many “bread and butter” PK studies.internship and residency at the University of California, San Francisco, Dr. Murray completed a fellowship in biological psychiatry at USCF, sponsored by the Department of Veterans Affairs. Dr. Murray began his industry career at Janssen Pharmaceuticals, where he was involved in the development of drugs for schizophrenia and bipolar disorder. He later moved to Pfizer, where he was involved in the development of Geodon (ziprasidone), and he eventually rose to the level of senior medical director overseeing the development of compounds for the treatment of schizophrenia, bipolar disorder, and cognitive disorders. Most recently, Dr. Murray has been the CMO for several biotech companies invol | | |
| | | Mardik Donikyan | | Director / Principal Investigator | | p. (646) 215.6400 | | e. info@clinilabs.com | | Dr. Donikyan is board certified in Emergency Medicine and has over 18 years of experience in this specialty. Dr. Donikyan has served as a PI in clinical research for the past 8 years and has extensive experience in metabolic disorders, GI, CNS and CV therapeutics. Dr. Donikyan recently has completed several early phase trials with both young and elderly populations.
| | |
| |
|